TH94275B - Interferon alpha and c-phycocyanin For the treatment of autoimmune diseases, allergies and cancer - Google Patents
Interferon alpha and c-phycocyanin For the treatment of autoimmune diseases, allergies and cancerInfo
- Publication number
- TH94275B TH94275B TH601005357A TH0601005357A TH94275B TH 94275 B TH94275 B TH 94275B TH 601005357 A TH601005357 A TH 601005357A TH 0601005357 A TH0601005357 A TH 0601005357A TH 94275 B TH94275 B TH 94275B
- Authority
- TH
- Thailand
- Prior art keywords
- phycocyanin
- treatment
- autoimmune diseases
- allergies
- cancer
- Prior art date
Links
- 206010003816 Autoimmune disease Diseases 0.000 title claims abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract 3
- 201000011510 cancer Diseases 0.000 title claims abstract 3
- 102000006992 Interferon-alpha Human genes 0.000 title abstract 2
- 108010047761 Interferon-alpha Proteins 0.000 title abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102100008763 IFNA2 Human genes 0.000 claims 1
- 108010079944 Interferon-alpha2b Proteins 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 239000000306 component Substances 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 238000010188 recombinant method Methods 0.000 claims 1
- 101700046422 IFNA Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 abstract 1
- 230000003110 anti-inflammatory Effects 0.000 abstract 1
- 230000001028 anti-proliferant Effects 0.000 abstract 1
- 230000000259 anti-tumor Effects 0.000 abstract 1
- 230000000840 anti-viral Effects 0.000 abstract 1
- 230000003078 antioxidant Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 210000003289 regulatory T cell Anatomy 0.000 abstract 1
Abstract
การประดิษฐ์นี้ประกอบด้วยการรวมเข้ากันของอินเตอร์เฟียรอนแอลฟา และ C-ไฟโค ไซยานิน (IFN-อัลฟา/C-ไฟโค) เพื่อให้ได้ส่วนเตรียมทางเภสัชกรรมสำหรับการรักษาโรคภูมิต้านตนเอง, ภูมิแพ้ และมะเร็ง ผลต้านการอักเสบ, ควบคุมภูมิคุ้มกัน, ต้านออกซิเดชัน, ต้านไวรัส, ต้านการเพิ่ม จำนวน และต้านเนื้องอก ที่สัมพันธ์กับผลเนี่ยวนำ T เซลล์ควบคุม (regulatory T cell inducer effect) ซึ่งแสดงไว้ในการประดิษฐ์นี้ เป็นเหตุผลสำหรับการใช้การรวมเข้ากันของ IFN-อัลฟา/C-ไฟโค ในโรค เหล่านี้ The invention consists of a combination of interferon alpha and C-phycocyanin (IFN-alpha / C-phycocyanin) to obtain a pharmaceutical preparation for the treatment of autoimmune diseases, Allergy and cancer anti-inflammatory, immune-regulating, anti-oxidative, antiviral, anti-proliferation and anti-tumor effects. This is related to the regulatory T cell inducer effect shown in this invention. As a reason for using a combination of IFN-alpha / C-phycocin in these diseases.
Claims (3)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH94275A TH94275A (en) | 2009-03-13 |
| TH94275B true TH94275B (en) | 2009-03-13 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2003002353A1 (en) | COMPOUNDS DERIVED FROM DIAMINOTRIAZOLS, INHIBITORS D ELA PROTEINA QUINASA; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND ITS USE OF THE COMPOUND IN THE TREATMENT OF DISEASES OF ALLERGIC DISORDERS, PROLIFERATION, AUTOIMMUNES, CONDIC | |
| BRPI0510526A (en) | stabilized liquid formulations of interferon | |
| ATE466085T1 (en) | PROTEASE-RESISTANT MODIFIED INTERFERON ALPHA POLYPEPTIDES | |
| EA200602137A1 (en) | HYDROGEL PREPARATIONS OF INTERFERON | |
| Lok | HCV NS5A inhibitors in development | |
| WO2007110231A3 (en) | MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES | |
| WO2006004959A3 (en) | Pegylated interferon alpha-1b | |
| HRP20050024A2 (en) | Pegylated t20 polypeptide | |
| NO20060374L (en) | Peptides and peptidomimetics with immunomodulatory, anti-inflammatory and anti-viral activity | |
| HRP20050585A2 (en) | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | |
| CA2627531A1 (en) | Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer | |
| EA200501699A1 (en) | STABILIZED INTERFERON LIQUID COMPOSITIONS, NOT CONTAINING HUMAN SERUM ALBUMIN | |
| RU2008100307A (en) | APPLICATION OF CYTOKINE FROM THE INTERLEUKIN-6 FAMILY TO OBTAIN A COMPOSITION FOR COMBINED INTRODUCTION WITH INTERFERON-ALPHA | |
| RU2009104749A (en) | RECOMBINANT PROTEINS SIMILAR TO HUMAN INTERFERON | |
| JP2008546672A5 (en) | ||
| DK1824504T3 (en) | Anti-tumor combinations containing VEGF trap and 5-fluorouracil or a derivative thereof | |
| ATE413187T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU | |
| ATE484290T1 (en) | PEPTIDE WITH ANTI-TUMORAL EFFECT | |
| ATE521624T1 (en) | PEPTIDES AND MEDICINAL COMPOSITIONS COMPRISING THE SAME | |
| TH94275B (en) | Interferon alpha and c-phycocyanin For the treatment of autoimmune diseases, allergies and cancer | |
| HUP0303309A2 (en) | Modified interferon alpha with reduced immunogenicity | |
| WO2000078266A3 (en) | Interferon tau mutants and methods for making them | |
| TH94275A (en) | Interferon alpha and c-phycocyanin For the treatment of autoimmune diseases, allergies and cancer | |
| ATE520412T1 (en) | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINIZING POLYRADICUONEUROPATHY WITH INTERFERON-BETA | |
| CY1112440T1 (en) | APLYGYLZYZYLENED AND DISINFECTED LONG PENTRAXIN PTX3 |